GLF Venture Inc

GLF Venture Inc For over 20 years GLF Venture, based in Victoria, BC, empowers global clients with data analytics, BI, and cybersecurity.

We turn key metrics into insights and offer digital copyrigths protection, brand integrity, and risk mitigation

04/20/2026
03/19/2026
03/17/2026

A question scientists have studied in laboratories for years was once tested by a child… with caterpillars at home.

Friends, the story begins with a young boy in Japan named Jo Nagai, who became fascinated by butterflies and the strange transformation they go through. During metamorphosis, a caterpillar forms a chrysalis and its body reorganizes before emerging as a butterfly. Because the transformation is so dramatic, scientists have long wondered whether anything from the caterpillar’s life can survive it, especially learned memories.

While reading about insect research, Nagai came across work by entomologist Martha Weiss, who studies learning and behavior in insects. Instead of stopping at curiosity, he decided to try a similar idea himself.

Nagai trained caterpillars to associate the scent of lavender with a mild electric stimulus. Over time the caterpillars learned to avoid the smell. Then he waited as they formed chrysalises and eventually emerged as butterflies.

What happened next surprised him.

When the butterflies were exposed to the lavender scent again, many still avoided it. Even after metamorphosis, the behavior appeared to remain.

Nagai later shared his observations with Weiss, who recognized the careful thinking behind the experiment. His work did not introduce a new scientific theory, but it reflected an idea researchers had already been exploring.

Sometimes science moves forward in large laboratories.

And sometimes it begins with a child curious enough to test a question himself.

https://www.facebook.com/share/1EwFsWLNDn/?mibextid=wwXIfr
01/03/2026

https://www.facebook.com/share/1EwFsWLNDn/?mibextid=wwXIfr

She was 12 years old when she realized that people were dying because doctors couldn't check their DNA fast enough—so she wrote a computer program that could do it in seconds instead of hours.
Her name is Sofia Tomov. And at age 12, she decided that if the world's leading scientists couldn't solve a problem fast enough, she'd solve it herself.
The problem starts with something most of us don't think about: every time a doctor prescribes medication, they're making an educated guess.
They know what usually works for most people. But they don't know if it will work for you specifically. Because hidden in your DNA might be a genetic mutation that makes that medication dangerous—even deadly.
Adverse drug reactions kill over 100,000 Americans every year. That makes it the fourth leading cause of death in the United States. Fourth. More than car accidents. More than diabetes.
People go to the hospital to get help, and the medication that's supposed to save them kills them instead.
Not because doctors made a mistake. But because they had no way of knowing that particular patient's DNA would react badly to that particular drug.
Scientists have known about this problem for years. The solution seems obvious: sequence the patient's genome, check for dangerous mutations, prescribe accordingly.
But there's a problem.
The human genome contains 6 billion base pairs. Analyzing all that data to find specific dangerous mutations takes hours. Sometimes days.
If someone is having a heart attack or a seizure, you don't have hours.
You need an answer in minutes, or that person dies.
For years, the smartest scientists in the world have been trying to solve this: how do you analyze 6 billion data points fast enough to save someone's life in an emergency?
They couldn't figure it out.
Sofia Tomov, a 12-year-old eighth grader from Knoxville, Tennessee, figured it out.
She wrote an algorithm—a computer program—that could analyze a patient's genome for dangerous drug-reaction mutations in a fraction of the time current methods required.
Let me say that again: a 12-year-old solved a problem that had stumped medical researchers worldwide.
How does a 12-year-old even know this problem exists?
Because Sofia isn't just interested in computers. She's interested in saving lives.
Before she tackled the drug reaction problem, Sofia had already filed a provisional patent for a device that safely disposes of medications so they don't contaminate the water supply.
At 11 years old, she was already thinking about how improper drug disposal was poisoning rivers and groundwater.
She filed a patent. At 11.
So when Sofia learned about adverse drug reactions—how thousands of people die every year from medications that their DNA made toxic—she didn't think "That's terrible." She thought "I can fix that."
The challenge was enormous. The human genome is incomprehensibly large. Six billion base pairs of information. Finding the specific mutations that cause drug reactions is like finding a handful of specific grains of sand on a beach.
And you need to do it in seconds, not hours, or the patient dies.
Current algorithms were too slow. They'd analyze the data thoroughly, but by the time they finished, the emergency patient would be dead.
Sofia needed to make it faster. Dramatically faster.
She dove into genetics research. She studied how adverse drug reactions happen at the molecular level. She learned about specific gene mutations—CYP2D6, CYP2C19, others—that metabolize drugs differently.
Then she started coding.
She built an algorithm that could scan a genome, identify the dangerous mutations, and deliver results fast enough to actually use in emergency situations.
The key was smart filtering. Instead of analyzing all 6 billion base pairs equally, her program focused on the specific regions most likely to contain dangerous mutations. It used machine learning to recognize patterns. It optimized processing speed without sacrificing accuracy.
Sofia's vision was simple but revolutionary: every patient gets their genome sequenced as part of routine medical care—maybe when they're born, maybe during a regular checkup. That data gets stored in their medical record.
Then, when they need medication—whether it's a routine prescription or an emergency situation—the doctor runs Sofia's algorithm. In seconds, it identifies which drugs are safe and which could be deadly for that specific patient.
No more guessing. No more deadly adverse reactions. Just precise, personalized medicine.
In 2016, Sofia entered the Discovery Education 3M Young Scientist Challenge—one of the most prestigious science competitions for middle school students in America.
She was competing against thousands of students from across the country. Many of them were older. All of them had impressive projects.
Sofia made it to the finals with her drug-reaction algorithm.
At 12 years old, she was presenting research to professional scientists that could genuinely save thousands of lives.
When asked about her vision for the project, Sofia didn't give a modest middle-school answer. She said: "I envision this as being extremely widespread."
She meant it. She wasn't thinking about winning a competition. She was thinking about implementing this globally. Hospitals worldwide. Millions of patients. Lives saved.
"For patients in emergency situations such as a heart attack or a seizure, this is a huge health risk," Sofia explained, discussing why current methods fail. Her solution addressed that risk directly.
Sofia knew her program wasn't ready for implementation yet. It would need more development, more testing, more refinement. But she'd proven the concept worked. She'd shown that the problem scientists said was too hard to solve could be solved.
By a 12-year-old.
Sofia's long-term goals were equally ambitious. She wanted to get a PhD in computer science. Start her own company focused on machine learning. Keep solving problems that save lives.
Her advice to other young scientists? "You can never do enough research about the topic."
That's how she approached every problem: exhaustive research, deep understanding, then innovation.
Think about what Sofia represents. She's not just smart—lots of kids are smart. She's not just interested in science—lots of kids love science.
Sofia looks at problems that adults have decided are too hard, and she decides to solve them anyway.
At 11, she thought about environmental contamination from drug disposal and invented a solution.
At 12, she thought about people dying from adverse drug reactions and wrote an algorithm to prevent it.
Most adults would look at these problems and think: "That's tragic, but what can I do? I'm not a scientist. I'm not qualified."
Sofia looked at these problems and thought: "People are suffering. I'm going to learn everything I need to learn to fix this."
She didn't wait for permission. She didn't wait until she was older or had a PhD or worked at a research institution.
She just started solving the problem.
That's not just intelligence. That's audacity. That's a 12-year-old girl deciding that she has the right—the responsibility—to tackle problems that affect millions of people.
Today, Sofia Tomov is in her twenties. She went to MIT. She's continued her work in computer science and machine learning. She's still focused on using technology to solve real-world problems.
But back in 2016, when she was 12 years old, she proved something important: age doesn't determine whether you can solve hard problems. Credentials don't determine whether your ideas are valuable.
What determines it is whether you're willing to do the research, learn what you need to learn, and actually build the solution.
Somewhere right now, there's another 12-year-old looking at a problem that adults say is too complex to solve.
Maybe that kid will remember Sofia Tomov. Maybe they'll think: if she could write an algorithm to prevent deadly drug reactions at 12, I can tackle the problem I'm thinking about.
Maybe that kid will invent something that saves lives too.
Because that's what Sofia really gave us. Not just an algorithm—though that's impressive enough. She gave us proof that you don't need to wait until you're an adult to make a difference.
You don't need a PhD to innovate. You don't need decades of experience to see solutions that others miss.
Sometimes you just need to be 12 years old, unaware that the problem is supposed to be impossible, and willing to try anyway.
Sofia saw people dying from adverse drug reactions. She saw scientists struggling to solve it. She saw a gap between what was needed and what existed.
And she filled it. With an algorithm she wrote herself. At 12.
Over 100,000 Americans die every year from adverse drug reactions. That number could drop dramatically if Sofia's vision becomes reality—if every patient gets genomically screened, if every prescription gets checked against their specific DNA, if doctors know with certainty which medications are safe.
That future is possible because a 12-year-old in Tennessee decided it should exist and started building it.
In honor of Sofia Tomov, who at age 11 filed a patent for a drug disposal device to protect the water supply, who at age 12 wrote an algorithm to prevent deadly adverse drug reactions, who made it to the finals of a national science competition with research that could save thousands of lives, and who proved that the biggest innovations sometimes come from people who don't yet know that problems are supposed to be impossible.
Because Sofia looked at a problem killing 100,000 people a year and thought: "I can fix that."
And she did. At 12.

11/25/2025

A 20-year-old medical student, Malone Mukwende, made a powerful impact on global healthcare when he created a handbook that helps doctors diagnose skin conditions on Black and Brown skin. While studying at St George’s, University of London, Malone noticed something alarming — almost all medical textbooks showed symptoms only on white skin. This meant that rashes, infections, allergic reactions, and even life-threatening conditions could be misdiagnosed on darker skin tones.

To fix this, Malone created a handbook called “Mind the Gap.” It shows clear photos, explanations, and guidance on how illnesses appear on darker skin. His mission is simple: improve medical training, prevent dangerous mistakes, and make healthcare safer for everyone. Doctors around the world have praised his work, and many universities now use the handbook to teach future healthcare professionals.

Malone’s project also highlights a bigger issue — the lack of representation in medical education. His work proves that change can begin with one person who dares to speak up. Today, his handbook is recognized globally as a tool that can literally save lives, especially in communities that have been overlooked for decades.

His story is an inspiring reminder that young people can create real solutions, break systems that don’t work, and bring fairness to healthcare. By pushing for inclusivity, Malone has improved medical awareness, inspired millions online, and sparked conversations that continue to reshape the medical world.

06/01/2025

Victoria Ou and Justin Huang, both 17-year-old students from College Park High School in The Woodlands, Texas, developed an innovative water filtration system that employs ultrasonic waves to remove microplastics from water. Their device achieved an impressive removal rate of 84% to 94% in laboratory tests, offering a promising solution to the pervasive environmental issue of microplastic contamination.
My Hero

Inspiration and Development
The duo's interest in addressing microplastic pollution was sparked during a visit to a local water treatment plant, where they learned about the challenges these facilities face in removing microplastics from water sources. This experience motivated them to create a more efficient and environmentally friendly solution. Their device utilizes high-frequency ultrasonic waves to generate acoustic radiation forces that repel microplastic particles, preventing them from passing through the filtration system. This method allows for efficient separation of microplastics without impeding water flow.
My Hero

Recognition and Awards
Their groundbreaking invention earned them the prestigious Gordon E. Moore Award for Positive Outcomes for Future Generations at the 2024 Regeneron International Science and Engineering Fair (ISEF) in Los Angeles. This award, supported by the Gordon and Betty Moore Foundation, includes a $50,000 prize and recognizes projects that demonstrate a significant and positive impact on future generations .
My Hero

In addition to the Gordon E. Moore Award, Ou and Huang received the Taking the Pulse of the Planet First Award from the National Oceanic and Atmospheric Administration (NOAA) for their innovative approach to microplastic removal .
Society for Science
+2
IGI Global
+2
NOAA
+2

Potential Applications
The team's ultrasonic filtration system holds promise for various applications, including:

Water Treatment Plants: Enhancing the removal of microplastics from municipal water supplies.

Household Appliances: Integrating the technology into washing machines to capture microplastics released during laundry cycles.

Industrial Use: Implementing the system in industries where water purification is essential.

By targeting microplastics at their source, such as synthetic fibers from clothing, this technology could significantly reduce the amount of microplastics entering the environment.

Ongoing Development
Currently, Ou and Huang are working to scale up and refine their prototype to enhance its efficiency and applicability in real-world settings. Their continued efforts aim to bring this innovative solution to broader use, contributing to cleaner water sources and a healthier environment.

For more information about their project, you can visit their ISEF project page: EAEV062T – Acoustic Filtration: Harnessing Ultrasonic Technology for the Streamlined Removal of Microplastic Particles From Water Flow. https://isef.net/project/eaev062t-harnessing-ultrasound-for-microplastic-filtration

Send a message to learn more

05/20/2025

Send a message to learn more

Desde GLF Venture Inc., con sede en Victoria, BC Canadá y raíces firmes en la admiración por el talento colombiano, expr...
05/15/2025

Desde GLF Venture Inc., con sede en Victoria, BC Canadá y raíces firmes en la admiración por el talento colombiano, expresamos nuestro total respaldo a la marca Frisby, ícono de la creatividad y el espíritu emprendedor de Colombia.

Hemos seguido con atención los recientes sucesos ocurridos en España, donde aparentemente se ha reportado el uso indebido de elementos asociados a la marca Frisby. Ante esto, alzamos nuestra voz como aliados internacionales del respeto por la propiedad intelectual y la protección del talento auténtico.

El talento colombiano no se copia… se protege, se admira y se respalda.

Colombia no solo exporta sabor, innovación y alegría, también exporta identidad. Desde GLF Venture Inc. apoyamos cualquier esfuerzo legal y diplomático que defienda los derechos de nuestras marcas nacionales y celebramos las iniciativas que reconocen su valor fuera del país.

¿Cómo apoyamos desde Canadá?

Difundiendo la historia y originalidad de marcas colombianas como Frisby.

Promoviendo la conciencia sobre la propiedad intelectual en mercados globales.

Estableciendo redes de apoyo (A-POLLO) empresarial entre Colombia y Canadá para proteger la innovación.

Rechazando cualquier forma de apropiación indebida que intente minimizar o lucrarse del trabajo ajeno.

Hoy más que nunca reafirmamos nuestro compromiso con la integridad, la identidad cultural y el emprendimiento con propósito.

GLF Venture Inc.
Innovación con raíz latina. Impacto global.

Nadie lo hace como Frisby lo hace

From GLF Venture Inc., headquartered in Victoria, BC, Canada, and with deep-rooted admiration for Colombian talent, we express our full support for the Frisby brand, an icon of creativity and entrepreneurial spirit in Colombia.

We have been closely following the recent events in Spain, where there have reportedly been instances of misuse of elements associated with the Frisby brand. In light of this, we raise our voice as international allies in defense of intellectual property and the protection of authentic talent.

Colombian talent is not copied... it is protected, admired, and supported.

Colombia exports not only flavor, innovation, and joy, it also exports identity. At GLF Venture Inc., we support any legal and diplomatic efforts that defend the rights of our national brands and celebrate initiatives that recognize their value abroad.

How do we support from Canada?

By sharing the history and originality of Colombian brands like Frisby.

By promoting awareness of intellectual property in global markets.

By establishing business support networks between Colombia and Canada to protect innovation.

By rejecting any form of misappropriation that seeks to diminish or profit from someone else’s work.

Now more than ever, we reaffirm our commitment to integrity, cultural identity, and purpose-driven entrepreneurship.

GLF Venture Inc.
Innovation with Latin roots. Global impact.

Nobody does it like Frisby does.

Address

1027 Pandora Avenue
Victoria, BC
V8V3P6

Alerts

Be the first to know and let us send you an email when GLF Venture Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to GLF Venture Inc:

Share